![Eric Siegel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Siegel
Consejero General en CARISMA THERAPEUTICS, INC. .
Perfil
Eric H.
Siegel is currently the Secretary & General Counsel at Carisma Therapeutics, Inc. He previously worked as the Chief Compliance Officer & Deputy General Counsel at Cephalon, Inc. from 2004 to 2007, General Counsel at Solstice Neurosciences, Inc. from 2007 to 2009, Executive Vice President & General Counsel at Incyte Corp.
in 2010-2011, Principal at GSK Plc, and Chief Compliance Officer at EMD Serono, Inc. in 2011.
He also served as the Chief Compliance Officer at Idorsia Pharmaceuticals US, Inc. Mr. Siegel received his graduate degree from the University of Pennsylvania, his MBA from Temple University, and his undergraduate degree from Franklin & Marshall College.
Cargos activos de Eric Siegel
Empresas | Cargo | Inicio |
---|---|---|
CARISMA THERAPEUTICS, INC. | Consejero General | 14/06/2023 |
Antiguos cargos conocidos de Eric Siegel.
Empresas | Cargo | Fin |
---|---|---|
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Oficial de Cumplimiento | 01/10/2011 |
Solstice Neurosciences, Inc.
![]() Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | Consejero General | - |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Oficial de Cumplimiento | - |
Idorsia Pharmaceuticals US, Inc. | Oficial de Cumplimiento | - |
INCYTE CORPORATION | Consejero General | - |
Formación de Eric Siegel.
University of Pennsylvania | Graduate Degree |
Temple University (Pennsylvania) | Masters Business Admin |
Franklin & Marshall College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
INCYTE CORPORATION | Health Technology |
GSK PLC | Health Technology |
CARISMA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Solstice Neurosciences, Inc.
![]() Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Idorsia Pharmaceuticals US, Inc. |
- Bolsa de valores
- Insiders
- Eric Siegel